Match tier Likely match
Presence Current · Arkansas
Last published 2021
Sources OpenAlex · ORCID
Refreshed 2026-10-07

David A. Thorn

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

Also affiliated: United States Food and Drug Administration (2021); University of Freiburg (2006); RTI International (2016); University at Buffalo, State University of New York (2011–2017)

15 h-index 28 pubs 669 cited

  • Animals
  • Male
  • Rats, Sprague-Dawley
  • Rats
  • Dose-Response Relationship, Drug
  • Imidazoline Receptors
  • Behavior, Animal
  • Pain
  • Benzofurans
  • Imidazoles
  • Cocaine
  • Receptors, G-Protein-Coupled
  • Ligands
  • Analgesics
  • Locomotion

Biography and Research Information

OverviewAI-generated summary

David A. Thorn's research focuses on the application of analytical techniques to toxicological studies. His work has explored the use of MALDI imaging mass spectrometry as a tool in neurological research. Thorn has published 28 papers, accumulating 650 citations and an h-index of 15. He has collaborated with researchers at the National Center for Toxicological Research, including E. Ellen Jones, Dustyn A. Barnette, and Laura K. Schnackenberg, with whom he shares publications. Thorn's research activity is current, with his most recent publication in 2021. His work draws on expertise in animal models, dose-response relationships, and the study of pharmacological effects and neurotoxicology.

Metrics

  • h-index: 15
  • Publications: 28
  • Citations: 669

Selected Publications

  • MALDI imaging mass spectrometry: an emerging tool in neurology (2021)
    Metabolic Brain Disease 40 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

3 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics